Selective 5-Hydroxytryptamine Type 3 Receptor Antagonism With Ondansetron as Treatment for Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study

CHARLES J. STEADMAN, NICHOLAS J. TALLEY, SIDNEY F. PHILLIPS, ALAN R. ZINSMEISTER

Research output: Contribution to journal › Article › peer-review

95 Scopus citations

Fingerprint

Dive into the research topics of 'Selective 5-Hydroxytryptamine Type 3 Receptor Antagonism With Ondansetron as Treatment for Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study'. Together they form a unique fingerprint.

Medicine & Life Sciences